Evidence supporting the use of: Butyric acid
For the health condition: Antibiotics (alternatives to)

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Butyric acid, a short-chain fatty acid produced by bacterial fermentation of dietary fibers in the gut, is increasingly studied as an alternative or adjunct to antibiotics, particularly for supporting gut health and managing infections. Its primary mechanism involves serving as an energy source for colonocytes, strengthening the intestinal barrier, and exerting anti-inflammatory properties. Scientific studies, mainly in vitro and animal models, have shown that butyric acid can inhibit the growth and virulence of pathogenic bacteria, modulate immune responses, and promote the growth of beneficial microbiota. In poultry and swine industries, butyrate supplementation has been used to reduce the reliance on antibiotics for growth promotion and infection control, with meta-analyses suggesting moderate efficacy in reducing pathogen load and improving gut health.

Human clinical evidence is more limited but growing. Some small trials suggest that butyrate supplementation (often as sodium butyrate) may help manage conditions like antibiotic-associated diarrhea and inflammatory bowel disease by restoring microbiota balance and supporting mucosal healing. However, butyric acid is not a direct antimicrobial, and its effect is primarily supportive, not curative. Overall, the evidence base is moderate (rated 3/5), and the use of butyric acid as an antibiotic alternative is justified by mechanistic rationale and animal/human studies, but more robust clinical trials are needed to establish definitive efficacy and guidelines for use in humans.

More about butyric acid
More about Antibiotics (alternatives to)